Get the Stockscreener App
1.41
3.68%
+0.05
Interpace Biosciences Inc. Stock (IDXG) Forecast
The Interpace Biosciences Inc. (IDXG) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.6337, representing a +157.71% increase from the current price of $1.41. The highest analyst price target is $3.7545, and the lowest is $3.5129.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IDXG Price Target
Average 5.4683
(+287.82% Upside)
Long-term IDXG price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Interpace Biosciences Inc. financial reports and earnings history, Interpace Biosciences Inc. (IDXG) stock could reach $37.27 by 2030, $68.42 by 2040 and $70.79 by 2050. See the projected annual prices until 2050 of the Interpace Biosciences Inc. stock below:
- Interpace Biosciences Inc. (IDXG) is expected to reach an average price of $24.44 in 2035, with a high prediction of $29.82 and a low estimate of $24.49. This indicates an $1,633% rise from the last recorded price of $1.41.
- Interpace Biosciences Inc. (IDXG) stock is projected to chart a bullish course in 2040, with an average price target of $60.55, representing an $4,194% surge from its current level. The forecast ranges from a conservative $60.55 to a sky-high $68.42.
- Our analysts predict Interpace Biosciences Inc. (IDXG) to jump 7,844% by 2045, soaring from $112.12 to an average price of $112.00, potentially reaching $122.81. While $112.12 is the low estimate, the potential upside is significant.
- Interpace Biosciences Inc. (IDXG) stock is expected to climb by 2050, reaching an average of $57.97, a $4,011% jump from its current level. However, a wide range of estimates exists, with high and low targets of $70.79 and $58.02, respectively, highlighting the market's uncertainty.
Interpace Biosciences Inc. Stock (IDXG) Year by Year Forecast
Interpace Biosciences Inc. Stock (IDXG) Price Forecast for 2024
Our forecast for IDXG stock price in 2024 now indicates an average price target of $3.9894 with a high forecast of $7.7788 and a low forecast of $0.1999. The average prediction reflects an increase of +182.93% from the last recorded price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $3.2621 | $3.5129 | $3.7545 | +131.35% |
| July, 2024 | $2.8789 | $2.7997 | $3.0813 | +104.18% |
| August, 2024 | $1.825 | $2.03 | $2.4081 | +29.43% |
| September, 2024 | $0.7682 | $0.2082 | $1.5392 | -45.52% |
| October, 2024 | $5.11 | $0.539 | $4.97 | +262.41% |
| November, 2024 | $6.7441 | $6.924 | $7.7788 | +378.30% |
| December, 2024 | $5.4893 | $5.7793 | $6.469 | +289.31% |
Interpace Biosciences Inc. Stock (IDXG) Price Forecast for 2025
Interpace Biosciences Inc. Stock (IDXG) is expected to reach an average price of $7.0623 in 2025, with a high prediction of $13.68 and a low estimate of $0.4465. This indicates an +400.87% rise from the last recorded price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $4.7184 | $4.7246 | $5.1769 | +234.64% |
| February, 2025 | $3.2536 | $3.5936 | $4.1622 | +130.75% |
| March, 2025 | $2.4689 | $2.5189 | $2.9874 | +75.10% |
| April, 2025 | $1.0234 | $0.4465 | $1.6003 | -27.42% |
| May, 2025 | $9.6537 | $8.145 | $10.73 | +584.66% |
| June, 2025 | $8.3903 | $8.4073 | $9.2321 | +495.06% |
| July, 2025 | $6.891 | $6.991 | $7.7557 | +388.72% |
| August, 2025 | $5.2131 | $5.2581 | $6.3994 | +269.72% |
| September, 2025 | $3.7867 | $4.3464 | $4.7515 | +168.56% |
| October, 2025 | $2.4536 | $1.432 | $3.4752 | +74.01% |
| November, 2025 | $12.54 | $11.18 | $13.68 | +789.65% |
| December, 2025 | $11.14 | $11.18 | $12.12 | +690.15% |
Interpace Biosciences Inc. Stock (IDXG) Price Forecast for 2026
The predicted value for Interpace Biosciences Inc. (IDXG) in 2026 is set at an average of $11.00. Estimates vary from a peak of $19.58 to a trough of $2.4175, indicating an +679.95% surge from the present price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $8.9012 | $9.0012 | $10.58 | +531.29% |
| February, 2026 | $7.2333 | $7.5733 | $8.3243 | +413.00% |
| March, 2026 | $5.6854 | $6.0104 | $6.7814 | +303.22% |
| April, 2026 | $2.4075 | $2.4175 | $5.0084 | +70.74% |
| May, 2026 | $15.99 | $3.4005 | $16.63 | +1,034% |
| June, 2026 | $14.06 | $14.29 | $15.14 | +897.07% |
| July, 2026 | $11.46 | $11.52 | $13.50 | +713.04% |
| August, 2026 | $9.4244 | $9.7644 | $10.85 | +568.40% |
| September, 2026 | $7.4749 | $7.6799 | $8.837 | +430.13% |
| October, 2026 | $3.393 | $3.403 | $6.8475 | +140.64% |
| November, 2026 | $19.61 | $4.3006 | $19.58 | +1,291% |
| December, 2026 | $17.18 | $17.36 | $18.67 | +1,118% |
Interpace Biosciences Inc. Stock (IDXG) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Interpace Biosciences Inc. (IDXG) is $14.93, with a high forecast of $25.48 and a low forecast of $4.3885. This indicates an +959.04% increase from the last price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $14.17 | $14.51 | $16.56 | +904.77% |
| February, 2027 | $12.08 | $12.12 | $13.56 | +756.47% |
| March, 2027 | $9.2451 | $9.5851 | $11.18 | +555.68% |
| April, 2027 | $4.5863 | $5.1463 | $8.6373 | +225.27% |
| May, 2027 | $20.29 | $4.3885 | $20.14 | +1,339% |
| June, 2027 | $20.43 | $20.55 | $22.53 | +1,349% |
| July, 2027 | $16.82 | $17.11 | $19.66 | +1,093% |
| August, 2027 | $14.35 | $14.35 | $16.08 | +917.65% |
| September, 2027 | $11.55 | $11.59 | $13.64 | +718.88% |
| October, 2027 | $8.2503 | $8.3003 | $10.74 | +485.13% |
| November, 2027 | $5.7374 | $5.374 | $6.1008 | +306.91% |
| December, 2027 | $23.12 | $23.24 | $25.48 | +1,540% |
Interpace Biosciences Inc. Stock (IDXG) Price Forecast for 2028
In 2028, Interpace Biosciences Inc. (IDXG) is projected to reach an average price of $18.87, with a high projection of $31.38 and a low estimate of $6.3595. This indicates an +1,238% rise from the last price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $20.15 | $20.17 | $22.27 | +1,329% |
| February, 2028 | $16.94 | $17.04 | $19.09 | +1,102% |
| March, 2028 | $13.13 | $13.17 | $16.02 | +831.17% |
| April, 2028 | $9.9952 | $10.55 | $12.24 | +608.88% |
| May, 2028 | $7.0009 | $6.3595 | $9.2566 | +396.52% |
| June, 2028 | $26.44 | $26.36 | $28.43 | +1,775% |
| July, 2028 | $23.33 | $23.36 | $25.58 | +1,554% |
| August, 2028 | $19.85 | $19.91 | $22.34 | +1,308% |
| September, 2028 | $15.58 | $15.92 | $18.89 | +1,005% |
| October, 2028 | $12.32 | $12.65 | $14.70 | +773.82% |
| November, 2028 | $7.335 | $7.345 | $11.22 | +420.21% |
| December, 2028 | $30.31 | $7.901 | $31.38 | +2,049% |
Interpace Biosciences Inc. Stock (IDXG) Price Forecast for 2029
The 2029 price forecast for Interpace Biosciences Inc. Stock (IDXG) is $21.83 on average, with a high prediction of $35.32 and a low estimate of $8.3305. This represents an +1,448% increase from the previous price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $26.67 | $26.90 | $29.04 | +1,792% |
| February, 2029 | $22.89 | $23.23 | $25.69 | +1,524% |
| March, 2029 | $18.19 | $18.53 | $21.94 | +1,190% |
| April, 2029 | $14.54 | $14.74 | $17.18 | +931.01% |
| May, 2029 | $8.8698 | $9.4298 | $13.48 | +529.07% |
| June, 2029 | $34.36 | $8.3305 | $34.33 | +2,337% |
| July, 2029 | $30.22 | $30.40 | $33.00 | +2,043% |
| August, 2029 | $25.07 | $25.41 | $29.17 | +1,678% |
| September, 2029 | $21.27 | $21.31 | $24.04 | +1,409% |
| October, 2029 | $16.73 | $17.07 | $19.95 | +1,087% |
| November, 2029 | $9.9407 | $10.50 | $15.70 | +605.02% |
| December, 2029 | $35.46 | $9.316 | $35.32 | +2,415% |
Interpace Biosciences Inc. Stock (IDXG) Price Forecast for 2030
Interpace Biosciences Inc. Stock (IDXG) is expected to reach an average price of $25.26 in 2030, with a high forecast of $40.22 and a low forecast of $10.30. This signifies an +1,692% surge from the last price of $1.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $33.89 | $34.01 | $37.27 | +2,304% |
| February, 2030 | $29.56 | $29.57 | $32.70 | +1,996% |
| March, 2030 | $23.97 | $23.97 | $28.15 | +1,600% |
| April, 2030 | $19.46 | $19.51 | $22.84 | +1,280% |
| May, 2030 | $14.03 | $14.08 | $18.23 | +895.16% |
| June, 2030 | $10.50 | $10.30 | $10.70 | +644.79% |
| July, 2030 | $37.55 | $37.93 | $40.22 | +2,563% |
| August, 2030 | $31.91 | $31.93 | $36.36 | +2,163% |
| September, 2030 | $26.99 | $27.09 | $30.42 | +1,814% |
| October, 2030 | $22.25 | $22.59 | $25.65 | +1,478% |
| November, 2030 | $16.20 | $16.76 | $21.03 | +1,049% |
| December, 2030 | $11.50 | $11.29 | $15.04 | +715.71% |
3.26%
0.02%
Cap:
|
Volume (24h):